A Combination of Methylation and Protein Markers is Capable of Detecting Gastric Cancer Detection by Combined Markers

References

• Chen W , ZhengR , BaadePDet al. Cancer statistics in China, 2015. CA Cancer J. Clin.66(2), 115–132 (2016).
   PubMed Web of Science ®Google Scholar
• Ychou M , DuffourJ , KramarA , GourgouS , GrenierJ. Clinical significance and prognostic value of CA724 compared with CEA and CA19-9 in patients with gastric cancer. Dis. Markers16(3-4), 105–110 (2000).
   PubMed Web of Science ®Google Scholar
• Emoto S , IshigamiH , YamashitaH , YamaguchiH , KaisakiS , KitayamaJ. Clinical significance of CA125 and CA724 in gastric cancer with peritoneal dissemination. Gastric Cancer15(2), 154–161 (2012).
   PubMed Web of Science ®Google Scholar
• Chen XZ , ZhangWH , YangKet al. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population. Tumour Biol.35(9), 9015–9022 (2014).
   PubMedGoogle Scholar
• Jing JX , WangY , XuXQet al. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Asian. Pac. J. Cancer Prev.15(23), 10267–10272 (2014).
   PubMedGoogle Scholar
• Liang Y , WangW , FangCet al. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA724 in patients with gastric cancer. Oncotarget7(31), 49565–49573 (2016).
   PubMedGoogle Scholar
• Chen HM , FangJY. Epigenetic biomarkers for the early detection of gastrointestinal cancer. Gastrointest. Tumors1(4), 201–208 (2014).
   PubMedGoogle Scholar
• Sonohara F , InokawaY , HayashiM , KoderaY , NomotoS. Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. Oncol. Lett.13(5), 3363–3368 (2017).
   PubMed Web of Science ®Google Scholar
• Song L , LiY. Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years. Biomark. Med.11(6), 415–418 (2017).
   PubMed Web of Science ®Google Scholar
• Song L , JiaJ , PengX , XiaoW , LiY. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis. Sci. Rep.7(1), 3032 (2017).
   PubMed Web of Science ®Google Scholar
• Song L , LiY. SEPT9: a specific circulating biomarker for colorectal cancer. Adv. Clin. Chem.72, 171–204 (2015).
   PubMed Web of Science ®Google Scholar
• Li Y , SongL , GongY , HeB. Detection of colorectal cancer by DNA methylation biomarker SEPT9 past, present and future. Biomark. Med.8(5), 755–769 (2014).
   PubMed Web of Science ®Google Scholar
• Cheung KF , LamCN , WuKet al. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer118(4), 947–959 (2012).
   PubMed Web of Science ®Google Scholar
• Xie XM , DengJY , HouYCet al. Evaluating the clinical feasibility: the direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer. Cancer Biomark.15(3), 259–265 (2015).
   PubMed Web of Science ®Google Scholar
• Deng J , LiangH , YingGet al. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer. Oncotarget5(10), 3173–3183 (2014).
   PubMedGoogle Scholar
• Zhang X , ZhangX , SunBet al. Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer. Oncol. Lett.8(4), 1745–1750 (2014).
   PubMed Web of Science ®Google Scholar
• Han F , SunLP , LiuSet al. Promoter methylation of RNF180 is associated with H. pylori infection and serves as a marker for gastric cancer and atrophic gastritis. Oncotarget7(17), 24800–24809 (2016).
   PubMedGoogle Scholar
• Deng J , GuoJ , GuoXet al. Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter. Oncotarget7(28), 43461–43474 (2016).
   PubMedGoogle Scholar
• Lofton-Day C , ModelF , DevosTet al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem.54(2), 414–423 (2008).
   PubMed Web of Science ®Google Scholar
• Dietrich D , JungM , PuetzerSet al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions. PLoS ONE8(12), e84225 (2013).
   PubMed Web of Science ®Google Scholar
• Powrózek T , KrawczykP , KucharczykT , MilanowskiJ. Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer preliminary report. Med. Oncol.31(4), 917 (2014).
   PubMed Web of Science ®Google Scholar
• Paska AV , HudlerP. Aberrant methylation patterns in cancer a clinical view. Biochem. Med. (Zagreb)25(2), 161–176 (2015).
   PubMed Web of Science ®Google Scholar
• Matsui S , KagaraN , MishimaCet al. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients. Oncol. Rep.36(4), 2225–2235 (2016).
   PubMed Web of Science ®Google Scholar
• Verdier-Pinard P , SalaunDet al. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments. Sci. Rep.7, 44976 (2017).
   PubMed Web of Science ®Google Scholar
• Wu Y , BuF , YuHet al. Methylation of septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis. Toxicol. Appl. Pharmacol.315, 35–49 (2017).
   PubMed Web of Science ®Google Scholar
• Kuo IY , ChangJM , JiangSSet al. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Int. J. Med. Sci.11(8), 779–787 (2014).
   PubMed Web of Science ®Google Scholar
• Cao CQ , ChangL , WuQ. Circulating methylated septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer. Transl. Cancer Res.9(11), 7012–7021 (2020).
   PubMed Web of Science ®Google Scholar
• Warren JD , XiongW , BunkerAMet al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med.9, 133 (2011).
   PubMed Web of Science ®Google Scholar
• Tóth K , SiposF , KalmárAet al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS ONE7(9), e46000 (2012).
   PubMed Web of Science ®Google Scholar
• Church TR , WandellM , Lofton-DayCet al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut63(2), 317–325 (2014).
   PubMed Web of Science ®Google Scholar
• Jin P , KangQ , WangXet al. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm. J. Gastroenterol. Hepatol.30(5), 830–833 (2015).
   PubMed Web of Science ®Google Scholar
• Wu D , ZhouG , JinPet al. Detection of colorectal cancer using a simplified SEPT9 gene methylation assay is a reliable method for opportunistic screening. J. Mol. Diagn.18(4), 535–545 (2016).
   PubMed Web of Science ®Google Scholar
• Song L , JiaJ , YuHet al. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location. J. Cancer Res. Clin. Oncol.143(6), 1093–1101 (2017).
   PubMed Web of Science ®Google Scholar
• Song L , PengX , LiYet al. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening. Epigenomics9(5), 599–610 (2017).
   PubMed Web of Science ®Google Scholar
• Schmidt B , LiebenbergV , DietrichDet al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer10, 600 (2010).
   PubMed Web of Science ®Google Scholar
• Schneider KU , DietrichD , FleischhackerMet al. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer11, 102 (2011).
   PubMed Web of Science ®Google Scholar
• Kneip C , SchmidtB , SeegebarthAet al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J. Thorac. Oncol.6(10), 1632–1638 (2011).
   PubMed Web of Science ®Google Scholar
• Dietrich D , KneipC , RajiOet al. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int. J. Oncol.40(3), 825–832 (2012).
   PubMed Web of Science ®Google Scholar
• Schmidt B , BeyerJ , DietrichD , BorkI , LiebenbergV , FleischhackerM. Quantification of cell-free mSHOX2 plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients. PLoS ONE10(2), e0118195 (2015).
   PubMed Web of Science ®Google Scholar
• Klutstein M , NejmanD , GreenfieldR , CedarH. DNA methylation in cancer and aging. Cancer Res.76(12), 3446–3450 (2016).
   PubMed Web of Science ®Google Scholar
• Song L , ChenY , GongYet al. Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers. Ther. Adv. Med. Oncol.16(12), 1758835920962966 (2020).
   Google Scholar
• Chen XZ , ZhangWK , YangKet al. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol. Biol. Rep.39(9), 9031–9039 (2012).
   PubMed Web of Science ®Google Scholar
• Tham C , ChewM , SoongRet al. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. Cancer120(20), 3131–3141 (2014).
   PubMed Web of Science ®Google Scholar
• Lee HS , HwangSM , KimTSet al. Circulating methylated septin 9 nucleic acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. Transl. Oncol.6(3), 290–296 (2013).
   PubMed Web of Science ®Google Scholar
• Schröck A , LeisseA , de VosLet al. Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients an observational prospective cohort study. Clin. Chem.63(7), 1288–1296 (2017).
   PubMed Web of Science ®Google Scholar
• de Vos L , GevenslebenH , SchröckAet al. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients. Clin. Epigenetics9, 125 (2017).
   PubMed Web of Science ®Google Scholar